BERTOLI, DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 904
EU - Europa 804
AS - Asia 258
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 1.972
Nazione #
US - Stati Uniti d'America 902
PL - Polonia 598
CN - Cina 125
UA - Ucraina 92
DE - Germania 40
SG - Singapore 40
HK - Hong Kong 30
VN - Vietnam 28
FI - Finlandia 20
IE - Irlanda 14
IT - Italia 13
TR - Turchia 13
ID - Indonesia 8
PK - Pakistan 8
FR - Francia 7
SE - Svezia 6
GB - Regno Unito 5
IN - India 5
RU - Federazione Russa 4
AU - Australia 3
BE - Belgio 2
CA - Canada 2
EU - Europa 2
BG - Bulgaria 1
CL - Cile 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
Totale 1.972
Città #
Warsaw 598
Fairfield 144
Woodbridge 88
Cambridge 73
Jacksonville 71
Seattle 64
Houston 60
Ann Arbor 58
Ashburn 52
Chandler 48
Wilmington 47
Dearborn 31
Hong Kong 30
Dong Ket 28
Princeton 28
Singapore 27
Nanjing 20
Beijing 17
Dublin 14
Shenyang 14
Helsinki 12
Istanbul 12
New York 12
Jinan 11
Shanghai 11
Nanchang 9
San Diego 9
Boardman 8
Des Moines 8
Faisalabad 8
Hebei 7
Jakarta 7
Changsha 6
Phoenix 5
Tianjin 5
Claremont 4
Kunming 4
Munich 4
Brescia 3
Milan 3
Ningbo 3
Taizhou 3
Brussels 2
Hangzhou 2
Hefei 2
Toronto 2
Zhengzhou 2
Athens 1
Brooklyn 1
Canberra 1
Chicago 1
Delhi 1
Guangzhou 1
Gunzenhausen 1
Hyderabad 1
Indiana 1
Karet Kuningan 1
Lanzhou 1
Lappeenranta 1
Leawood 1
London 1
Los Angeles 1
Melbourne 1
New Bedfont 1
Parma 1
Putignano 1
Redwood City 1
Rome 1
Sofia 1
Sydney 1
Vientiane 1
Washington 1
Wuhan 1
Totale 1.702
Nome #
Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients. 251
Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients 211
Modulation of Regulatory T-cell Subsets in Very Long-term Treated Aviremic HIV(+) Patients and Untreated Viremic patients 199
Immunological biomarkers identifying natalizumab-treated multiple sclerosis patients at risk of progressive multifocal leukoencephalopathy 196
B-and T-lymphocyte number and function in HIV+/HIV- lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation 183
Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy 143
Long-Lasting production of New T and B Cells and T-Cell Repertoire Diversity in Patients with Primary Immunodeficiency Who Had Undergone Stem Cell Transplantation : A Single-Centre Experience 139
Cryptococcal-related meningoencephalitis in a patient with sarcoidosis and CD4 lymphocytopenia: thorough immunological characterization of lymphocyte homeostasis 128
T-cell receptor and K-deleting recombination excision circles in newborn screening of T- and B-cell defects : review of the literature and future challenges 120
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing 96
Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies 95
Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy 82
Early reduction of the splicing factor2/alternative splicing factor: a cellular inhibitor of the JC polyomavirus in natalizumab-treated MS patients long before developing progressive multifocal leukoencephalopathy 76
Identification of Relapse Risk Using a Multiparameter Flow Cytometry-Based Detection of Minimal Residual Disease in Adult Patients with Acute Myeloid Leukemia at ELN Intermediate-Risk 64
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 17
Totale 2.000
Categoria #
all - tutte 6.993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.993


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020537 0 0 0 0 58 93 75 82 68 91 35 35
2020/2021408 19 36 20 51 25 43 19 52 33 51 18 41
2021/2022114 11 4 4 11 1 11 1 12 5 11 13 30
2022/2023122 17 1 0 8 18 34 0 12 19 1 4 8
2023/2024126 13 2 9 7 1 27 5 5 34 3 4 16
2024/202573 2 4 1 41 25 0 0 0 0 0 0 0
Totale 2.000